Osteologie 2011; 20(02): 149-151
DOI: 10.1055/s-0037-1619991
Stellungnahme des DVO
Schattauer GmbH

Diskussion über die optimale Dosis von Vitamin D

P. Burckhardt
1   P. Burckhardt, Facharzt FMH für Innere Medizin, Endokrinologie und Diabetologie, Clinique Bois-Cerf, Lausanne, Schweiz
,
M. Amling
2   Osteologisches Schwerpunktzentrum DVO, Zentrum für Biomechanik und Skelettbiologie, Klinik für Unfall-, Hand-, und Wiederherstellungschirurgie, Universitätsklinikum Hamburg Eppendorf
,
H. Dobnig
3   Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Österreich
,
L. C. Hofbauer
4   Bereich Endokrinologie/Diabetes/metabolische Knochenerkrankungen, Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
,
F. Jakob
5   Orthopädisches Zentrum für Muskuloskelettale Forschung, Orthopädische Klinik, König-Ludwig Haus, Universität Würzburg
› Author Affiliations
Further Information

Publication History

eingereicht: 06 May 2011

angenommen: 01 June 2011

Publication Date:
30 December 2017 (online)

 

 
  • Literatur

  • 1 Webb AR, Kline L, Holick MF. Influence of Season and Latitude on the Cutaneous Synthesis of Vitamin D3: Exposure to Winter Sunlight in Boston and Edmonton Will Not Promote Vitamin D3 Synthesis in Human Skin. J Clin Endocrinol Metab 1988; 67 (02) 373-378.
  • 2 Hintzpeter B. et al. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2007; 62 (09) 1079-1089.
  • 3 Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004; 80 (06) 1710S-1716S.
  • 4 IOM: Report on Dietary Reference Intakes (DRIs) for calcium and vitamin D by the Institute of Medicine (IOM). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2010
  • 5 Lappe JM, Travers-Gustafson D, Davies KM. et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591.
  • 6 Bischoff-Ferrari HA, Willett WC, Wong JB. et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. A metanalysis of randomized controlled trials. Arch Intern Med 2009; 169 (06) 551-561.
  • 7 Priemel M. et al. Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. Journal of Bone and Mineral Research 2009; 25 (02) 305-312.
  • 8 Bischoff-Ferrari HA, Dawson-Hughes B, Platz A. et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture. Arch Intern Med 2010; 170 (09) 813-820.
  • 9 Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 1999; 69: 842-856.
  • 10 Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116 (09) 634-639.
  • 11 Boonen S, Bischoff-Ferrari HA, Cooper C. et al. Adressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calc Tissue Int 2006; 78: 257-270.
  • 12 Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin H. et al. Fall prevention with supplemental and acive form of vitamin D: A meta-analysis of randomized trials. BMJ 2009; 339: b3692.
  • 13 Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for Cancer Prevention: Global perspective (Review). Annals Epidemiology 2009; 19: 468-483.
  • 14 Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer - ready for prime time?. New Engl J Med 2011; 364: 1385-1387.
  • 15 Dobnig H, Pilz S, Scharnagel H. et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Archives Internal Medicine 2008; 168 (12) 1-10.